Combining MALDI-TOF and molecular imaging with principal component analysis for biomarker discovery and clinical diagnosis of cancer

Genomic Medicine, Biomarkers, and Health Sciences

Volumn 4, Issue 1-2, 2012, Pages 3-6

  Cho, Yi Tzu ^a   Chiang, Yi Yan ^b   Shiea, Jentaie ^b   Hou, Ming Feng ^c  

^a Yuh Ing Junior College of Health Care and Management   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Diagnosis; Matrix assisted laser desorption ionization mass spectrometry; Molecular imaging; Principle component analysis; Tissue

Indexed keywords

LIPID; PEPTIDE;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLITE; MOLECULAR IMAGING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; TISSUE SECTION;

EID: 84861574749     PISSN: 22114254     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gmbhs.2012.04.022     Document Type: Article

References (15)

1. Tanaka K., Hiroaki W., Yutaka I., et al. Protein and polymer analyses up to m/z 100000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1988, 2:151-153.
2. Karas M., Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10000 daltons. Anal Chem 1988, 60:2299-2301.
3. Fuchs B., Schiller J. Application of MALDI-TOF mass spectrometry in lipidomics. Eur J Lipid Sci Technol 2009, 111:83-98.
4. Su A.K., Liu J.T., Lin C.H. Rapid drug-screening of clandestine tablets by MALDI-TOF mass spectrometry. Talanta 2005, 67:718-724.
5. Shiea J., Cho Y.T., Lin Y.H., et al. Rapid Commun Mass Spectrom 2008, 22:3754-3760.
6. Lin S.Y., Shih S.H., Wu D.C., et al. Rapid Commun Mass Spectrom 2007, 21:3311-3316.
7. Caprioli R.M., Farmer T.B., Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997, 69:4751-4760.
8. Kristen D.H., Stacey R.O., Richard M.C. Semin Nephrol 2007, 27:597-608.
9. Caprioli R.M. Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res 2005, 65:10642-10645.
10. Hsieh Y., Chen J., Korfmacher W.A. Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometry. J Pharmacol Toxicol Methods 2007, 55:193-200.
11. Walch A., Rauser S., Deininger S.O., et al. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 2008, 130:421-434.
12. Wang H.Y., Lo L.H., Tyan Y.C. The study of the distribution of melamine in rat renal tissues by imaging mass spectrometry. Anal Methods 2010, 2:1974-1981.
13. Ragazzi E., Pucciarell S., Seraglia R., et al. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. J Mass Spectrom 2006, 41:1546-1553.
14. Djidja M.C., Claude E., Snel M.F., et al. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 2010, 397:587-601.
15. Yao I., Sugiura Y., Matsumoto M., et al. In situ proteomics with imaging mass spectrometry and principal component analysis in the Scrapper-knockout mouse brain. Proteomics 2008, 8:3692-3701.